List of Tables
Table 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Adeno Carcinomas
Table 3. Key Players of Mucinous Carcinomas
Table 4. Key Players of Adenosquamous Carcinomas
Table 5. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region (2019-2024)
Table 9. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region (2025-2030)
Table 11. mRNA Cancer Vaccines and Therapeutics Market Trends
Table 12. mRNA Cancer Vaccines and Therapeutics Market Drivers
Table 13. mRNA Cancer Vaccines and Therapeutics Market Challenges
Table 14. mRNA Cancer Vaccines and Therapeutics Market Restraints
Table 15. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players (2019-2024)
Table 17. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2023)
Table 18. Ranking of Global Top mRNA Cancer Vaccines and Therapeutics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
Table 22. Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2019-2024)
Table 30. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2025-2030)
Table 32. North America mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Moderna Therapeutics Company Detail
Table 48. Moderna Therapeutics Business Overview
Table 49. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 50. Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 51. Moderna Therapeutics Recent Development
Table 52. CureVac Company Detail
Table 53. CureVac Business Overview
Table 54. CureVac mRNA Cancer Vaccines and Therapeutics Product
Table 55. CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 56. CureVac Recent Development
Table 57. Translate Bio Company Detail
Table 58. Translate Bio Business Overview
Table 59. Translate Bio mRNA Cancer Vaccines and Therapeutics Product
Table 60. Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 61. Translate Bio Recent Development
Table 62. BioNTech Company Detail
Table 63. BioNTech Business Overview
Table 64. BioNTech mRNA Cancer Vaccines and Therapeutics Product
Table 65. BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 66. BioNTech Recent Development
Table 67. Sangamo Therapeutics Company Detail
Table 68. Sangamo Therapeutics Business Overview
Table 69. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 70. Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 71. Sangamo Therapeutics Recent Development
Table 72. Argos Therapeutics Company Detail
Table 73. Argos Therapeutics Business Overview
Table 74. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 75. Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 76. Argos Therapeutics Recent Development
Table 77. In-Cell-Art Company Detail
Table 78. In-Cell-Art Business Overview
Table 79. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product
Table 80. In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 81. In-Cell-Art Recent Development
Table 82. eTheRNA Company Detail
Table 83. eTheRNA Business Overview
Table 84. eTheRNA mRNA Cancer Vaccines and Therapeutics Product
Table 85. eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 86. eTheRNA Recent Development
Table 87. Ethris Company Detail
Table 88. Ethris Business Overview
Table 89. Ethris mRNA Cancer Vaccines and Therapeutics Product
Table 90. Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 91. Ethris Recent Development
Table 92. Tiba Biotechnology Company Detail
Table 93. Tiba Biotechnology Business Overview
Table 94. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product
Table 95. Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 96. Tiba Biotechnology Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global mRNA Cancer Vaccines and Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Adeno Carcinomas Features
Figure 4. Mucinous Carcinomas Features
Figure 5. Adenosquamous Carcinomas Features
Figure 6. Global mRNA Cancer Vaccines and Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Infectious Disease Case Studies
Figure 9. Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. mRNA Cancer Vaccines and Therapeutics Report Years Considered
Figure 12. Global mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players in 2023
Figure 16. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2023
Figure 18. North America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2019-2030)
Figure 20. United States mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Country (2019-2030)
Figure 24. Germany mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Share by Region (2019-2030)
Figure 32. China mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2019-2030)
Figure 40. Mexico mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Share by Country (2019-2030)
Figure 44. Turkey mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Moderna Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 47. CureVac Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 48. Translate Bio Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 49. BioNTech Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 50. Sangamo Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 51. Argos Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 52. In-Cell-Art Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 53. eTheRNA Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 54. Ethris Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 55. Tiba Biotechnology Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed